Clinical research

Incidence, time course and predictors of early vs. late target lesion revascularisation after everolimus-eluting stent implantation: a SPIRIT V substudy

EuroIntervention 2013;9:353-359 published online ahead of print March 2013. DOI: 10.4244/EIJV9I3A57

Giampaolo Niccoli
Giampaolo Niccoli1*, MD, PhD; Marrianne Stuteville2, BSN; Krishnankutty Sudhir2, MD, PhD; Dong Li2, MS; Rocco A. Montone1, MD; Leonardo Bolognese3, MD; Eberhard Grube4, MD
1. Institute of Cardiology, Catholic University of the Sacred Heart, Rome, Italy; 2. Abbott Vascular, Diegem, Belgium, and Santa Clara, CA, USA; 3. Azienda USL 8, Arezzo, Italy; 4. University of Bonn, Bonn, Germany

Aims: To evaluate the incidence, time course and predictors of late target lesion revascularisation (TLR) (between one and two years) as

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

clinical researcheverolimus-eluting stentlate catch-uptarget lesion revascularisation
Read next article
The impact of gender on fractional flow reserve measurements

Latest news